Abstract
Cardiac toxicity is a public health issue that can be caused by both environmental and occupational exposures. The current study aimed to investigate the effectiveness of carvedilol (CV), Acetovanillone (ACET), and their combination for ameliorating cadmium (Cd)-induced oxidative stress, inflammation, and necroptosis. Rats were assigned to; the normal group, Cd group (2 mg/kg; i.p., single dose), and the other three groups received orally CV (10 mg/kg), ACET (25 mg/kg), and CV plus ACET, respectively and a single dose of Cd. Oral administration of CV, ACET, and their combination significantly dampens cardiac oxidative injury by increasing antioxidants GSH and SOD levels, while it decreases MDA and NADPH oxidase levels mediated by decreasing cardiac abundance of Nrf2, HO-1, and SIRT1 and downregulating KEAP-1 and FOXO-3 levels. Also, they significantly attenuated inflammatory response as indicated by reducing MPO and NOx as well as proinflammatory cytokines TNF-α and IL-6 mediated by downregulating TLR4, iNOS, and NF-κB proteins expression as well as IκB upregulation. Moreover, they potently counteracted cardiac necroptosis by downregulating RIPK1, RIPK3, MLKL, and caspase-8 proteins expression. Of note, the combination of CV and ACET have marked protection that exceeded each drug alone. Conclusively, CV ad ACET potently mitigated Cd-induced cardiac intoxication by regulating NADPH oxidase, KEAP-1/Nrf2/HO-1, SIRT1/FOXO-3, TLR4/NF-κB/iNOS, and RIPK1/RIPK3/MLKL signals.
Similar content being viewed by others
Introduction
Heavy metal toxicity is a public health issue that can be caused by both environmental and occupational exposures. It endangers the environment and public health due to the widespread presence of metals in the earth's crust, and it can result in significant multiple organ damage and death after exposure to acute or chronic phase1. Like other toxic heavy metals, cadmium (Cd) is a very hazardous environmental pollutant that has been shown to cause toxicity in a variety of organs and cells2,3. Significantly, previous investigations have shown that Cd poisoning causes biochemical and pathological alterations in the heart, which eventually leads to cardiac dysfunctions in humans4,5 and animal models6. Cd causes cardiac damage by generating reactive oxygen species (ROS)7,8. Interestingly, the nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) signal is a defensive mechanism in response to oxidative and chemical stress by promoting the expression of antioxidants9. Under oxidative or chemical stress, kelch-like ECH-associated protein-1 (KEAP-1), the inhibitor of Nrf2, dissociates from Nrf2 and leads to its activation, and mediates cardiac protection10,11.
Toll-like receptors (TLRs) are pattern recognition receptors, which are a crucial component of the innate immune system12. Importantly, TLR4 mediates the inflammatory response in the heart13,14. Notably, Cd toxicity has a significant influence on TLRs and their downstream signaling process, and previous studies have shown that Cd activates the TLR gene in human epithelial cells via a stimulated TLR4-mediated signaling pathway15,16. Significantly, the TLR4 signal has been shown in multiple studies to govern the production of proinflammatory molecules and promote the inflammatory response in cardiac tissues, which is the main cause of myocardial tissue injury by activating nuclear factor-kappa B (NF-κB)17,18. Also, necroptosis, a type of programmed necrosis, is carried out via the activation of receptor-interacting protein kinase 3 (RIPK3) and its downstream substrate mixed lineage kinase-like domain (MLKL), which are both mediated by death receptors and play a crucial role in inflammation and cell death. The importance of necroptosis in heart diseases has been strongly supported by recent investigations19.
Interestingly, carvedilol (CV) is commonly used to treat different heart diseases. It also aids in preventing oxygen radicals from causing damage to nitric oxide-mediated coronary artery dilation20. CV has been shown to have potent cardioprotection mediated by antioxidative, anti-antiapoptotic properties21,22. Acetovanillone (ACET) is a natural phytochemical obtained from Apocynum cannabinum and Picrorhiza kurroa. ACET is believed to act as an antioxidant because it prevents the activity of the ROS-producing enzyme nicotinamide adenine nucleotide phosphate oxidase (NADPH), such as superoxide anion (O2−), and thus may be useful in the treatment of a variety of illnesses that evoked by an elevated inflammatory response. Besides its antioxidant, it also possesses anti-inflammatory effects in a variety of in vitro and animal models23. Therefore, based on the above evidence, we hypothesize that CV, ACET, or their combination could attenuate Cd-induced oxidative stress, inflammation, and necroptosis. As a result, we want to look into whether CV and ACET can protect rats from Cd-induced cardiac damage or not.
Materials and methods
Chemicals, primers, and antibodies
Carvedilol was purchased from GNP company (6th of October, Giza, Egypt). Cadmium chloride (CdCl2) and ACET were purchased from Sigma Aldrich (St. Louis, MO, USA). Rat tumor necrosis factor-alpha (TNF-α; CAT# E-EL-R2856), troponin-I (CAT# E-CL-R0721), and (IL-6; CAT# E-EL-R0015) ELISA kits were purchased from ELABSCIENCE (Wuhan, China). Primers for Sirtuin 1 (SIRT1), Forkhead box O3 (FOXO3), KEAP-1, Nrf2, and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) genes were synthesized by Vivantis Technologies (Malaysia). Anti-RIPK1 (CAT# PA5-20811), anti-RIPK3 (CAT# PA5-19956), anti-MLKL (CAT# PA5-115578), and anti-caspase-8 (CAT# PA5-20118) were purchased from ThermoFisher Scientific (USA). Anti-iNOS (CAT# sc-7271), IκB (CAT# sc-1643), and anti-TLR4 (CAT# sc-293072) were purchased from Santa Cruz (USA). Anti-NF-κB (CAT# abx012874) was purchased from Abbexa (Germany). Anti-NADPH oxidase (CAT# E-AB-70215) and anti-β-actin (CAT# E-AB-20031) were purchased from ELABSCIENCE (China). Anti-Nrf2 (CAT# YPA1865) and anti-HO-1 (CAT# YPA1919) were purchased from Biospes (China). ACET and CV dissolved in 0.5% carboxymethyl cellulose (CMC).
Animal source and handling
Forty healthy male Wistar rats, averaging 12–14 weeks old, weighing between 180 and 200 g, were used in our study. Rats were purchased from the central animal house, Faculty of Medicine, Assiut University (Assiut, Egypt). A 12-h light/12-h dark cycle was used to keep the rats. Standard rodent food (not less than 19% proteins, 6% fibers, 3.5% fats, and 6.5% ash) and water are freely available to the animals. The rats were adapted to housing conditions for about seven days before the experimental design.
Experimental design and samples collection
Male Wistar rats (n = 40), were randomly allotted into five groups, named control, Cd, ACET-Cd, CV-Cd, and ACET + CV-Cd groups, as follows:
-
Group 1: (Served as the normal control group).
-
Group 2: (To induce cardiotoxicity, the Cd-control group was injected with CdCl2 (2 mg/kg, i.p.) on day 5)24.
-
Group 3: (CV, served as CV-treated group, rats administered with CV (10 mg/kg, p.o.) for 10 days and injected with CdCl2 (2 mg/kg, i.p.) on the 5th day of the experiment)25.
-
Group 4: (ACET, served as ACET-treated group, rats administered with ACET (25 mg/kg, p.o.) for 10 days and injected with CdCl2 (2 mg/kg, i.p.) on the 5th day of the experiment)26.
-
Group 5: (ACET plus CV, combination-treated group, rats were administered with ACET plus CV for 10 days and injected with CdCl2 (2 mg/kg, i.p.) on the 5th day of the experiment.
At the end of the experiment, all animals were anesthetized by i.p. administration of 100 mg/kg ketamine. In all groups, blood samples were collected retroorbitally for the determination of complete blood pictures (CBC). Serum was obtained after centrifugation at 4000 rpm for 10 min at 4 °C that was used for aspartate transaminase (AST), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), creatine kinase myocardial band (CK-MB) and troponin-I evaluation. The anesthetized rats were sacrificed, and the cardiac tissue was cut into four sections. The first section was homogenized in phosphate buffer saline solution for the evaluation of oxidative stress biomarkers. The second section of cardiac tissue was mixed with lysis buffer for blotting analysis. The third section was mixed with RNAlater for real-time PCR estimation. The last section was fixed in a 10% formaldehyde solution for histopathological and immunohistochemical estimation.
Assessment of heart function biomarkers
Serum CK-MB (CAT# 41254; Spinreact, Spain), ALP (CAT# 1001132; Spinreact, Spain), AST (CAT# 1001162; Spinreact, Spain), LDH (CAT# 1001260; Spinreact, Spain), and troponin-I were evaluated using commercial kits following the manufacturer’s directions.
Histopathologic examination
Hematoxylin and eosin (H&E) staining and light microscopical examination of the heart paraffin blocks sectioned at a thickness of 4-µm was performed according to the method described by Bancroft and Steven27. A semiquantitative scoring system of histopathological findings was conducted according to the previously reported method28. The parameters of pathological changes observed were tabulated and graded using a scale of 0–4, where: (0): indicates the absence of the parameters in the samples or healthy myocardium. (1): indicating observed presence and distribution of the parameter up to 25% of the area examined (0–25%). (2): indicating observed presence and distribution of the parameter between 26 to 50% of the area examined (26–50%). (3): indicating observed presence and distribution of the parameter between 51 and 75% of the area examined (51–75%). (4): indicating observed presence and distribution of the parameter in more than 75% of the area examined (76–100%).
Estimation of hematological indices
Hematological indices were estimated by conducting a complete blood count (CBC) using CellTac MEK-6510 (Japan) according to standard procedure29.
Measurement of oxidative stress and antioxidant enzymes
The enzyme activity of myeloperoxidase (MPO) was estimated spectrophotometrically based on the peroxidation of dimethoxybenzidine by H2O2 in the presence of the enzyme according to the method described by Manktelow and Meyer30. Cardiac determination of reduced glutathione (GSH) and total nitrite end product (NO2-) levels were done according to the previously described methods by Sedlak and Lindsay31 and Montgomery and Dymock32, respectively. Colorimetric evaluation of superoxide dismutase (SOD) activity was performed according to the methods described by Marklund33, respectively. Lipid peroxidation was measured as malondialdehyde (MDA) according to the principle described earlier by Uchiyama and Mihara34.
ELISA for proinflammatory cytokines
Cardiac TNF-α and IL-6 were measured by enzyme-linked immunosorbent assay according to the manufacturer's instructions. In brief, quantitative determination of TNF-α and IL-6 protein expression was performed by the addition of tissue samples containing TNF-α and IL-6 to microliter plates coated with purified rat TNF-α and IL-6 antibodies. Proteins of TNF-α and IL-6 combined with TNF-α and IL-6 antibodies labeled with avidin-HRP complex. This complex reacts with the TMB substrate to produce a blue color which converts to yellow color after sulfuric acid addition. The produced yellow color was measured at 450 nm using Readwell Strip, Elisa Reader, India.
Immunohistochemistry
Using various grades of xylene and ethanol solutions, sections with a 4 µm thickness were placed on slides and deparaffinized. The slides were blocked with 1% BSA following antigen retrieval in citrate buffer (pH = 6). Primary antibodies for anti-iNOS (dilution 1:50), anti-NF-κB (dilution 1:50), and anti-TLR4 (dilution 1:50) antibodies were then incubated on the slides for an overnight period at 4 °C. A species-matched secondary antibody was added after washing to visually inspect the reaction for an hour at room temperature. The sections were counterstained with hematoxylin. The photos were taken with a digital camera attached to a light microscope. The area percentage of immunoreactivity was calculated using the ImageJ® program.
Quantitative real-time PCR
Total RNA was isolated from cardiac tissues using the Trizol reagent (Invitrogen, USA) according to the manufacturer’s standard instructions. Then, the obtained RNA was reverse-transcribed into cDNA following the manufacturer's instructions. Utilizing the sequence of a specific primer for each target gene, the generated cDNA was used for quantitative RT-PCR on the target genes. GAPDH was utilized as an internal control gene. Following the completion of the PCR amplification, the GAPDH Ct was subtracted from each sample's Ct to determine the expression of each targeted gene35. The primer sequences are registered in Table 1.
Western blotting
The protein levels of RIPK1, RIPK3, MLKL, and caspase-8 were assessed using western blot analysis. Protein concentrations were determined via Bradford protein assays36. Protein (50-μg) from each sample was loaded onto a 12.5% polyacrylamide gel. After electrophoresis, the proteins were transferred to a PVDF membrane using a semi-dry transfer method37. The membrane was incubated with primary antibodies (anti-RIPK1 (dilution 1:1000), anti-RIPK3 (dilution 1:1000), anti-MLKL (dilution 1:1000), anti-caspase-8 (dilution 1:1000), anti-NF-κB (dilution 1:2000), anti-NADPH oxidase (dilution 1:1000), anti-Nrf2 (dilution 1:500), anti-HO-1 (dilution 1:500), and anti-β-actin (dilution 1:3000)) overnight at 4 °C after being blocked with 5 percent defatted milk for 1 h. After 1 h at room temperature with an ALP-conjugated secondary antibody, the membrane was subjected to three washes with 0.1% TBS-Tween 20. The membrane was then subjected to detection using a BCIP/NPT detection kit after being rinsed five times with 0.1% TBS-Tween20. ImageJ® software was used to quantify the bands. The protein levels were normalized by β-actin38.
Statistical analysis
Statistical analysis was performed using GraphPad Prism software (GraphPad Software, version 7, USA). All values are presented as means ± SEM. Comparisons between groups were analyzed by a one-way ANOVA using Tukey’s post-hoc test at P < 0.05. Histopathological analysis was performed using Kruskal–Wallis followed by Tukey’s as post-hoc comparison test at P < 0.05.
Ethical statement
This study was reviewed, and the protocol was approved by the Faculty of Pharmacy Animal Care and Use Committee of Al-Azhar University, Assiut Branch, Egypt (Approval number: ZA-AS/PH/4/C/2022). The current study adheres to the ARRIVE Guidelines for reporting in vivo experiments67. All experiments fulfill the guidelines of the National Institutes of Health guide for the care and use of laboratory animals (NIH Publications No. 8023, revised 1978)68 and the recommendations of Egypt's guide for the care and use of laboratory animals69.
Results
CV and ACET and their combination attenuate Cd-induced cardiac injury
To determine the cardioprotective effects of CV and ACET and their combinations against Cd-induced myocardial intoxication, serum CK-MB, ALP, AST, LDH, and troponin-I were measured as indicating heart function biomarkers. As shown in Fig. 1, Cd injection resulted in a remarkable increase in serum CK-MB (Fig. 1A), ALP (Fig. 1B), AST (Fig. 1C), LDH (Fig. 1D), and troponin-I (Fig. 1E) levels by 204.3%, 182%, 192.5%, 294.4%, and 545% respectively, concerning that of the normal rats. On the contrary, these changes were counteracted in rats given either CV or ACET and their combinations. Of note, the combination of CV and ACET have marked protection exceeded each drug alone and exhibited values closer to the levels seen in the serum of normal control rats.
CV and ACET and their combination attenuate Cd-induced cardiac histological abrasions
Histological examinations notably confirmed the cardioprotective effect of CV and ACET and their combination. The normal heart of the normal control rats presents the characteristic histological structure of cardiomyocytes. They were marked as thin, branched, elongated cylinders, cross-striated along with large oval central nuclei (thick arrow). Also, constricted slit-like interstices were observed in between (wave arrow). On the other hand, a rat’s heart injected with Cd highlights serious degenerative changes along myocardial fibers with loss of their normal architecture (two-head arrow), vacuolations (circle), and hyalinization of myofibrils (thin arrow), apoptotic myocytes (thick arrow), inflammatory cells infiltration (arrowhead), interstitial edema leading to dispersion between myofibrils (wave arrow), congested blood vessels (star) encircled by intermittent myofibrils (cube), and hemorrhage was dispersed in between myofibrils (triangle). Rat’s heart was treated with Cd and CV revealing little improvement along heart tissue structure demonstrated by restoring most regularity of myofibrils but hemorrhage was still seen in few amounts (cube), cardiac myocytes appeared in two forms, normal (thick arrow) as well as apoptotic one (thin arrow). Hyalinized myofibrils (wave arrow), leucocytic cell infiltration (arrowhead), and interstitial edema leading to dispersion between myofibrils (two-head arrow) were also observed. Rat’s heart was injected with Cd and treated with ACET exhibiting a marked development evidenced by almost regular cardiac myocytes (thick arrow). Congestion of blood vessels, (wave arrow), mild hemorrhage (and little interstitial edema (thin arrow) are marked in between cardiac myofibrils. Interestingly, rat hearts treated with CV and ACET disclosed the best enhancement along tissue structure. Nearly all myocardial fibers restore normal assembly with large oval central nuclei of its myocytes (thick arrow) except some hemorrhage still presented between myofibrils (thin arrow) (Fig. 2).
Furthermore, as shown in Fig. 3, quantitative analysis of histopathological findings showed that injection of Cd significantly increased all histopathological findings as indicated before compared to the control group (P < 0.05). However, most of these changes were significantly reversed by CV, ACET, and their combination treatment as compared to the Cd control group (P < 0.05).
CV, ACET, and their combination fixed Cd-induced hematological abnormalities
The effect of CV, ACET, and their combinations on hematological indices was evaluated by CBC analysis. in the present study, Cd exposure caused a significant alteration in the total leukocyte and neutrophil count, and neutrophil/lymphocyte ratio. Notably, pretreatment with CV, ACET, and their combination markedly reverse Cd-induced hematological alteration with higher values in the combination therapy than in monotherapy (Fig. 4).
CV and ACET and their combination attenuate Cd-induced cardiac oxidative injury
To assess the effect of CV and ACET on Cd-induced cardiac oxidative damage, the non-enzymatic antioxidant GSH (Fig. 5A), antioxidant enzyme and SOD (Fig. 5B), as well as the lipid peroxidation biomarker MDA (Fig. 5C) were determined. In Cd control rats, cardiac GSH and SOD levels were significantly decreased by 71%, and 65.3% respectively, whereas the cardiac MDA content was significantly increased by 203.4% relative to normal control rats. Conversely, co-treatment of Cd with CV, ACET, and their combination effectively increased GSH levels by 73.4%, 100.1%, and 246.5% respectively, and SOD levels by 109.9%, 126.3%, and 162.4% respectively, while it decreased MDA content by 34.2%, 40.6%, and 61.3% respectively, in the heart of rats.
CV and ACET and their combination modulate redox-sensitive signals in Cd-induced cardiac intoxication in rats
At the molecular level, the effect of CV and ACET and their combination on oxidant/antioxidant signals were assessed. Cardiac protein expression of NADPH oxidase was significantly upregulated (2.96 fold) after animals exposure to Cd as compared to normal control rats (Fig. 6B). This upregulation was concomitant with significant downregulation of both total and nuclear Nrf2 (Fig. 6C,D) by − 0.25 and − 0.88 folds respectively, and HO-1 (Fig. 6E) expressions by − 0.83 fold as compared to normal control rats. Interestingly, oral administration of CV, ACET, and their combination significantly decreased cardiac NADPH oxidase expression and increased total and nuclear Nrf2 and HO-1 expression as compared to the Cd control group (Fig. 6). Additionally, the mRNA expression of redox-sensitive signals KEAP-1/Nrf2 and SIRT1/FOXO-3 were assessed using a qRT-PCR assay. In this regard, when compared to normal rats, the heart of rats injected with Cd alone showed a significant down-regulation of Nrf2 (Fig. 6F) and SIRT1 (Fig. 6H) mRNA expression by − 0.73 and − 0.71 folds respectively, while the level of KEAP-1 (Fig. 6G) and FOXO-3 (Fig. 6I) significantly upregulated by 3.3 and 3.9 folds respectively. On the other side, compared to the Cd control group, oral administration of CV, ACET, and their combination significantly increased cardiac mRNA abundance of Nrf2 and SIRT1, and downregulated both KEAP-1 and FOXO-3 mRNA expressions effectively (Fig. 6). As compared to each drug alone, combination therapy exhibited the best results regarding all redox-sensitive pathways.
CV and ACET and their combination suppress cardiac inflammation in Cd-intoxicated rats
Herein, Cd injection markedly upregulated MPO (Fig. 7A) and NOx (Fig. 7B) by 251.5% and 217.2% respectively, as well as proinflammatory cytokines TNF-α (Fig. 7C) and IL-6 (Fig. 7D) by 403.4% and 449.6% respectively, in the heart of rats compared to normal control rats. On the other side, CV, ACET, and their combination significantly attenuated these changes. Notably, the combination of CV and ACET brings them closer to the levels seen in normal control rats (Fig. 7). Additionally, we emphasized our results by investigating the protein expression of NF-κB (total and nuclear) and IκB in heart tissue using western blot assay. In parallel to other results, Cd injection caused a significant upregulation of NF-κB (total and nuclear) expression by 2.85 and 21.2 folds respectively, concomitant with downregulation of IκB cardiac protein expression by − 0.65-fold as compared to normal control rats (Fig. 7E–H). Interestingly, oral administration of CV, ACET, and their combinations significantly restored the balance between NF-κB and IκB as compared to the Cd control group (Fig. 7). Notably, the combination of CV and ACET exhibited a significant modulation of NF-κB/IκB compared to each drug alone.
CV and ACET and their combination suppress iNOS/TLR4/NF-κB signal in Cd-intoxicated rats
Then, we aimed to explore more about the molecular mechanisms of the anti-inflammatory effects of CV and ACET on Cd-induced myocardial intoxication. Therefore, we examined their effects on iNOS/TLR4/NF-κB signals using the IHC technique. The results showed that Cd-intoxicated rats had a statistically significant increase in immunopositive expressions of iNOS (5.7-fold), TLR4 (6.8-fold), and NF-κB (2.6-fold) compared to the normal rats. Conversely, treatment with CV, ACET, and their combination dramatically reduced TLR4, iNOS, and NF-κB protein expressions as compared to the Cd control group (Fig. 8).
CV and ACET suppress cardiac necroptosis in Cd-intoxicated rats
Furthermore, we aimed to explore the role of necroptosis in Cd-induced myocardial intoxication. Therefore, we examined the expression levels of RIPK1, RIPK3, MLKL, and caspase-8 proteins using the W.B technique. Our data revealed that Cd-intoxicated rats had a statistically significant increase in RIPK1 (Fig. 9A), RIPK3 (Fig. 9B), MLKL (Fig. 9C), and caspase-8 (Fig. 9D) proteins by 4.2, 3.1, 2.7, and 3.5 folds respectively, compared to the normal rats. On the other side, treatment with CV, ACET, and their combination potently downregulated RIPK1, RIPK3, MLKL, and caspase-8 proteins expression.
Discussion
International legislation has placed restrictions on Cd exposure. Individuals may be exposed to Cd at work or in the environment in a variety of ways, which could have public health repercussions. Ingestion of Cd-contaminated food and water is the primary source of exposure for nonsmokers39. In terms of the cardiovascular system, there is a growing body of epidemiological data suggesting Cd has a negative impact on heart health40. Cd deposition and accumulation in the heart and vascular tissue have also been found in humans41 and laboratory animals42. Cd accumulates in the body because of its lengthy half-life, which ranges from 10 to 40 years43. Epidemiological surveys also show a link between Cd and cardiovascular diseases44,45.
For the first time, the potential protective impact of CV, ACET, and their combinations on Cd-induced cardiac intoxication were revealed in this investigation. The serum levels of CK-MB, ALP, AST, LDH, and troponin were all significantly increased after a Cd injection. In contrast, when rats were given CV, ACET, or a combination of the two, these changes were reversed. On histological analysis, we found significant structural and functional changes in the Cd-control rats. Priya et al. (2017) revealed significant cardiac histological, functional, and biochemical changes in Cd-intoxicated rats46.
Several studies reported the significance of oxidative stress in the pathogenesis of cardiovascular diseases47. Cell membranes are the primary targets for Cd toxicity, followed by lipid peroxidation, protein oxidation, and thiol reduction48. The current study's findings show a rise in myocardial LPO levels following Cd administration, which could be due to an excess of free radical production and a reduction in antioxidant defense. In contrast, the administration of CV, ACET, and their combinations successfully decreased the levels of LPO and potently increased antioxidants in Cd-injected rats, indicating that CV, ACET, and their combinations had anti-lipid peroxidative and antioxidant actions.
Interestingly, the transcription factor Nrf2 has been found to regulate genes involved in cell signaling, transcription, and organ development. Significantly, Nrf2 is involved in cardiovascular disease and regulates the expression of antioxidant and detoxifying genes. The evidence suggests that Nrf2 protects the heart in experimental models of atherosclerosis, ischemia, heart failure, and others9. A growing body of research indicates that the transcription factor Nrf2 is essential for regulating the production of antioxidant genes, which ultimately have anti-inflammatory effects by suppressing NF-κB activation and cytokines production49. Moreover, SIRT1, a class III histone deacetylase that is NAD+-dependent, has been demonstrated to improve cell resistance and survival to stress. SIRT1 overexpression upregulates antioxidants, protecting the heart from oxidative stress50,51. Additionally, SIRT1 was reported to suppress NF-κB activation, a crucial controller of the proinflammatory signaling pathway52. The current study also showed that rats exposed to Cd had much lower levels of Nrf2, HO-1, and SIRT1 in the heart and significantly higher levels of NADPH oxidase, KEAP-1, and FOXO-3. In contrast, CV, ACET, and their combinations had antioxidant and anti-inflammatory effects that increased Nrf2 and SIRT1 expression levels. Our findings are consistent with earlier studies53,54,55,56. These data imply that CV and ACET's protection against Cd-induced myocardial oxidative stress may be due to KEAP-1/Nrf2/HO-1/SIRT1 upregulation concomitant with NADPH oxidase inhibition.
Increased levels of ROS may activate the first step in the signaling process that activates redox-sensitive NF-κB signaling57,58. Heart diseases have all been linked to increased iNOS expression. iNOS is a protein that is produced in the heart in response to inflammatory stimuli and produces NO. NO overproduction is cytotoxic and has been linked to cardiovascular disease. In addition, iNOS produces superoxide anion, which combines with NO to form the damaging oxidant peroxynitrite, resulting in cardiac oxidative injury59,60. Peroxynitrite is a powerful oxidant that causes cell necrosis or apoptosis. It is hazardous to cells due to DNA and protein changes and is one of the most potent oxidants in biological systems61. Simultaneously, several investigators discovered that NF-κB activation plays a key role in Cd-induced myocardial injury62,63. NF-κB inhibition improved Cd-induced heart damage, according to Ansari, et al.64 and Ge, et al.65. Here, Cd injection significantly increased MPO, NOx, and the inflammatory cytokines TNF-α and IL-6 in the rat heart mediated by TLR4/iNOs/NF-κB activation. On the other hand, these effects were greatly mitigated by CV, ACET, and their combination.
It has been suggested that necroptosis plays a significant role in the pathogenesis of various heart conditions66. Therefore, treating cardiovascular disorders may benefit from focusing on necroptosis signaling pathways. Consequently, we aimed to explore the role of necroptosis in Cd-induced myocardial intoxication as a novel possible mechanism of pathogenesis of Cd-induced cardiac intoxication. Our study showed that rats given Cd injections had considerably upregulated RIPK1, RIPK3, MLKL, and caspase-8. As a result, our research adds to the growing body of data indicating the RIPK1/RIPK3/MLKL signal is crucial to Cd-induced necrosis and sheds light on how Cd causes cardiac intoxication. Conversely, CV, ACET, and their combinations appear to prevent this signaling activation by suppressing cardiac necroptosis. It is noteworthy that our study is the first to shed light on CV and ACET anti-necrotic and anti-apoptotic functions in relation to the regulation of necroptosis signaling.
Future work is recommended to assess the effects of chronic exposure to Cd on the heart and its correlation with its accumulation in heart tissue to find out whether Cd tissue accumulation correlates with cardiac toxicity parameters (Supplementary information).
Conclusions
In the present investigation, the administration of CV, ACET, and their combination significantly dampens cardiac oxidative injury by modulating NADPH oxidase, KEAP-1/Nrf2/HO-1, and SIRT1/FOXO-3. Also, they significantly attenuated inflammatory response by downregulating TLR4/iNOS/NF-κB signal. Moreover, they potently counteracted cardiac necroptosis by downregulating the RIPK1/RIPK3/MLKL signal. Of note, the combination of CV and ACET has marked protection that exceeded each drug alone. These promising effects were attributed to the potent antioxidative, anti-inflammatory, and anti-necroptotic activities of CV and ACET.
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding authors upon reasonable request.
References
Imam, R., Motawei, A. & AbdAlgaleel, W. Cadmium-induced adrenal cortical autophagy in rats: Possible modulation by sildenafil. Folia Morphol. 79, 709–719. https://doi.org/10.5603/FM.a2019.0126 (2020).
Ren, Y. et al. Mechanism of cadmium poisoning on testicular injury in mice. Oncol. Lett. 18, 1035–1042. https://doi.org/10.3892/ol.2019.10418 (2019).
Santos-Gallego, C. G. & Jialal, I. Cadmium and atherosclerosis: Heavy metal or singing the blues?. Atherosclerosis 249, 230–232. https://doi.org/10.1016/j.atherosclerosis.2016.01.041 (2016).
Järup, L. & Akesson, A. Current status of cadmium as an environmental health problem. Toxicol. Appl. Pharmacol. 238, 201–208. https://doi.org/10.1016/j.taap.2009.04.020 (2009).
Oyinloye, B. E., Ajiboye, B. O., Ojo, O. A., Nwozo, S. O. & Kappo, A. P. Cardioprotective and antioxidant influence of aqueous extracts from sesamum indicum seeds on oxidative stress induced by cadmium in wistar rats. Pharmacogn. Mag. 12, S170-174. https://doi.org/10.4103/0973-1296.182155 (2016).
Erdem, O., Yazihan, N., Kocak, M. K., Sayal, A. & Akcil, E. Influence of chronic cadmium exposure on the tissue distribution of copper and zinc and oxidative stress parameters in rats. Toxicol. Ind. Health 32, 1505–1514. https://doi.org/10.1177/0748233714566875 (2015).
Dailiah Roopha, P. & Padmalatha, C. Effect of herbal preparation on heavy metal (cadmium) induced antioxidant system in female Wistar rats. J. Med. Toxicol. 8(101–107), 2012. https://doi.org/10.1007/s13181-011-0194-y (2012).
Del Pino, J. et al. Higher sensitivity to cadmium induced cell death of basal forebrain cholinergic neurons: A cholinesterase dependent mechanism. Toxicology 325, 151–159. https://doi.org/10.1016/j.tox.2014.09.004 (2014).
Chen, Q. M. & Maltagliati, A. J. Nrf2 at the heart of oxidative stress and cardiac protection. Physiol. Genom. 50, 77–97. https://doi.org/10.1152/physiolgenomics.00041.2017 (2018).
Keum, Y. S., Owuor, E. D., Kim, B. R., Hu, R. & Kong, A. N. Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC). Pharm. Res. 20, 1351–1356. https://doi.org/10.1023/a:1025737622815 (2003).
Vashi, R. & Patel, B. M. NRF2 in cardiovascular diseases: A ray of hope!. J. Cardiovasc. Transl. Res. 14, 573–586. https://doi.org/10.1007/s12265-020-10083-8 (2021).
Lundberg, A. M. et al. Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis. Cardiovasc. Res. 99, 364–373. https://doi.org/10.1093/cvr/cvt033 (2013).
Chimenti, C. et al. Myocardial expression of Toll-like receptor 4 predicts the response to immunosuppressive therapy in patients with virus-negative chronic inflammatory cardiomyopathy. Eur. J. Heart Fail 19, 915–925. https://doi.org/10.1002/ejhf.796 (2017).
Lu, M. et al. Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway. Phytother. Res. 29, 599–606. https://doi.org/10.1002/ptr.5297 (2015).
Lucas, K. & Maes, M. Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: Possible treatments targeting the TLR4 pathway. Mol. Neurobiol. 48, 190–204. https://doi.org/10.1007/s12035-013-8425-7 (2013).
Song, S. Y., Bae, C. H., Choi, Y. S. & Kim, Y. D. Cadmium induces mucin 8 expression via Toll-like receptor 4-mediated extracellular signal related kinase 1/2 and p38 mitogen-activated protein kinase in human airway epithelial cells. Int. Forum Allergy Rhinol. 6, 638–645. https://doi.org/10.1002/alr.21705 (2016).
Luo, M. et al. Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4/NF-kB/NLRP3 pathway. J. Cell Biochem. 121, 2994–3004. https://doi.org/10.1002/jcb.29556 (2020).
Xiao, Z. et al. Ferrostatin-1 alleviates lipopolysaccharide-induced cardiac dysfunction. Bioengineered 12, 9367–9376. https://doi.org/10.1080/21655979.2021.2001913 (2021).
Guo, X., Chen, Y. & Liu, Q. Necroptosis in heart disease: Molecular mechanisms and therapeutic implications. J. Mol. Cell Cardiol. 169, 74–83. https://doi.org/10.1016/j.yjmcc.2022.05.006 (2022).
Magadmi, R. M., Alsulaimani, M. A., Al-Rafiah, A. R. & Esmat, A. The neuroprotective effect of carvedilol on diabetic neuropathy: An in vitro study. J. Diabetes Res. 2021, 6927025. https://doi.org/10.1155/2021/6927025 (2021).
Yeoh, T. et al. A randomised, placebo-controlled trial of carvedilol in early familial dilated cardiomyopathy. Heart Lung Circ. 20, 566–573. https://doi.org/10.1016/j.hlc.2011.06.004 (2011).
Pereira, G. C. et al. Drug-induced cardiac mitochondrial toxicity and protection: From doxorubicin to carvedilol. Curr. Pharm. Des. 17, 2113–2129. https://doi.org/10.2174/138161211796904812 (2011).
Simons, J. M., Hart, B. A., Ip Vai Ching, T. R., Van Dijk, H. & Labadie, R. P. Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils. Free Radical Biol. Med. 8, 251–258. https://doi.org/10.1016/0891-5849(90)90070-y (1990).
Saksena, S., White, M. J., Mertzlufft, J. & Lau, I. Prevention of cadmium-induced sterility by zinc in the male rat. Contraception 27, 521–530. https://doi.org/10.1016/0010-7824(83)90049-5 (1983).
de Araújo Júnior, R. F. et al. Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis. PLoS ONE 8, e66391. https://doi.org/10.1371/journal.pone.0066391 (2013).
Köroğlu, K. M., Çevik, Ö., Şener, G. & Ercan, F. Apocynin alleviates cisplatin-induced testicular cytotoxicity by regulating oxidative stress and apoptosis in rats. Andrologia 51, e13227. https://doi.org/10.1111/and.13227 (2019).
El-Shoura, E. A. M., Messiha, B. A. S., Sharkawi, S. M. Z. & Hemeida, R. A. M. Perindopril ameliorates lipopolysaccharide-induced brain injury through modulation of angiotensin-II/angiotensin-1-7 and related signaling pathways. Eur. J. Pharmacol. 834, 305–317. https://doi.org/10.1016/j.ejphar.2018.07.046 (2018).
Molh, A. K. et al. Histopathological studies of cardiac lesions after an acute high dose administration of methamphetamine. Malay. J. Med. Sci. 15, 23–30 (2008).
Ali, F. E. M. et al. Regulation of IL-6/STAT-3/Wnt axis by nifuroxazide dampens colon ulcer in acetic acid-induced ulcerative colitis model: Novel mechanistic insight. Life Sci. 276, 119433. https://doi.org/10.1016/j.lfs.2021.119433 (2021).
Manktelow, A. & Meyer, A. A. Lack of correlation between decreased chemotaxis and susceptibility to infection in burned rats. J. Trauma 26, 143–148. https://doi.org/10.1097/00005373-198602000-00008 (1986).
Sedlak, J. & Lindsay, R. H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal. Biochem. 25, 192–205. https://doi.org/10.1016/0003-2697(68)90092-4 (1968).
Montgomery, H. & Dymock, J. J. S. P., Milton Rd, Cambridge. Determination of nitrite in water, Royal Soc Chemistry Thomas Graham House. (1961).
Marklund, S. L. Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB/c mice. Mutat. Res./Fundamental Mol. Mech. Mutagenesis 148, 129–134 (1985).
Mihara, M. & Uchiyama, M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86, 271–278. https://doi.org/10.1016/0003-2697(78)90342-1 (1978).
Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(− Delta Delta C(T)) Method. Methods (San Diego, Calif.) 25, 402–408. https://doi.org/10.1006/meth.2001.1262 (2001).
Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254. https://doi.org/10.1016/0003-2697(76)90527-3 (1976).
Towbin, H., Staehelin, T. & Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350–4354. https://doi.org/10.1073/pnas.76.9.4350 (1979).
Ali, F. E. M., Bakr, A. G., Abo-Youssef, A. M., Azouz, A. A. & Hemeida, R. A. M. Targeting Keap-1/Nrf-2 pathway and cytoglobin as a potential protective mechanism of diosmin and pentoxifylline against cholestatic liver cirrhosis. Life Sci. 207, 50–60. https://doi.org/10.1016/j.lfs.2018.05.048 (2018).
Faroon, O. et al. Toxicological profile for cadmium. (2013).
Lee, M. S., Park, S. K., Hu, H. & Lee, S. Cadmium exposure and cardiovascular disease in the 2005 Korea National Health and Nutrition Examination Survey. Environ. Res. 111, 171–176. https://doi.org/10.1016/j.envres.2010.10.006 (2011).
Egger, A. E. et al. Chemical imaging and assessment of cadmium distribution in the human body. Metallomics 11, 2010–2019. https://doi.org/10.1039/c9mt00178f (2019).
Young, J. L. et al. Cadmium and high-fat diet disrupt renal, cardiac and hepatic essential metals. Sci. Rep. 9, 14675. https://doi.org/10.1038/s41598-019-50771-3 (2019).
Nordberg, G. F., Fowler, B. A. & Nordberg, M. Handbook on the Toxicology of Metals (Academic Press, 2014).
Tellez-Plaza, M. et al. Cadmium exposure and incident cardiovascular disease. Epidemiology 24, 421–429. https://doi.org/10.1097/EDE.0b013e31828b0631 (2013).
Larregle, E. V. et al. Lipid metabolism in liver of rat exposed to cadmium. Food Chem. Toxicol. 46, 1786–1792. https://doi.org/10.1016/j.fct.2008.01.018 (2008).
Priya, L. B. et al. Tinospora cordifolia extract attenuates cadmium-induced biochemical and histological alterations in the heart of male Wistar rats. Biomed. Pharmacother. 87, 280–287. https://doi.org/10.1016/j.biopha.2016.12.098 (2017).
Ho, E., Karimi Galougahi, K., Liu, C. C., Bhindi, R. & Figtree, G. A. Biological markers of oxidative stress: Applications to cardiovascular research and practice. Redox. Biol. 1, 483–491. https://doi.org/10.1016/j.redox.2013.07.006 (2013).
Stohs, S. J., Bagchi, D., Hassoun, E. & Bagchi, M. Oxidative mechanisms in the toxicity of chromium and cadmium ions. J. Environ. Pathol. Toxicol. Oncol. 19, 201–213 (2000).
Saha, S., Buttari, B., Panieri, E., Profumo, E. & Saso, L. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules https://doi.org/10.3390/molecules25225474 (2020).
Alcendor, R. R. et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 100, 1512–1521. https://doi.org/10.1161/01.RES.0000267723.65696.4a (2007).
Nadtochiy, S. M. et al. SIRT1-mediated acute cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 301, H1506-1512. https://doi.org/10.1152/ajpheart.00587.2011 (2011).
Hwang, J. W., Yao, H., Caito, S., Sundar, I. K. & Rahman, I. Redox regulation of SIRT1 in inflammation and cellular senescence. Free Radical Biol. Med. 61, 95–110. https://doi.org/10.1016/j.freeradbiomed.2013.03.015 (2013).
Amirshahrokhi, K. & Zohouri, A. Carvedilol prevents pancreatic β-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory cytokines, NF-κB, COX-2, iNOS and oxidative stress. Cytokine 138, 155394. https://doi.org/10.1016/j.cyto.2020.155394 (2021).
Abdel-Aziz, A. M. et al. Potential role of carvedilol in intestinal toxicity through NF-κB/iNOS/COX-2/TNF-α inflammatory signaling pathway in rats. Immunopharmacol. Immunotoxicol. https://doi.org/10.1080/08923973.2022.2072327 (2022).
Sayed, A. M. et al. Regulation of Keap-1/Nrf2/AKT and iNOS/NF-κB/TLR4 signals by apocynin abrogated methotrexate-induced testicular toxicity: Mechanistic insights and computational pharmacological analysis. Life Sci. 284, 119911. https://doi.org/10.1016/j.lfs.2021.119911 (2021).
Abd El-Ghafar, O. A. M. et al. Hepatoprotective effect of acetovanillone against methotrexate hepatotoxicity: Role of Keap-1/Nrf2/ARE, IL6/STAT-3, and NF-κB/AP-1 signaling pathways. Phytother. Res. PTR. 36, 488–505. https://doi.org/10.1002/ptr.7355 (2022).
Kwak, J. H., Jung, J. K. & Lee, H. Nuclear factor-kappa B inhibitors; a patent review (2006–2010). Expert Opin. Ther. Pat. 21, 1897–1910. https://doi.org/10.1517/13543776.2011.638285 (2011).
Aggarwal, B. B. Nuclear factor-kappaB: The enemy within. Cancer Cell 6, 203–208. https://doi.org/10.1016/j.ccr.2004.09.003 (2004).
Searles, C. D. The nitric oxide pathway and oxidative stress in heart failure. Congest. Heart Fail. 8, 142–155 (2002).
Wilmes, V. et al. Increased inducible nitric oxide synthase (iNOS) expression in human myocardial infarction. Int. J. Legal. Med. 134, 575–581. https://doi.org/10.1007/s00414-019-02051-y (2020).
Szabó, C., Ischiropoulos, H. & Radi, R. Peroxynitrite: Biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6, 662–680 (2007).
Das, S. C., Varadharajan, K., Shanmugakonar, M. & Al-Naemi, H. A. Chronic cadmium exposure alters cardiac matrix metalloproteinases in the heart of Sprague-Dawley Rat. Front. Pharmacol. 12, 663048. https://doi.org/10.3389/fphar.2021.663048 (2021).
Zhao, X., Wang, S., Li, X., Liu, H. & Xu, S. Cadmium exposure induces TNF-α-mediated necroptosis via FPR2/TGF-β/NF-κB pathway in swine myocardium. Toxicology 453, 152733. https://doi.org/10.1016/j.tox.2021.152733 (2021).
Ansari, M. N. et al. Protective role of Roflumilast against cadmium-induced cardiotoxicity through inhibition of oxidative stress and NF-κB signaling in rats. Saudi Pharm. J. 27, 673–681. https://doi.org/10.1016/j.jsps.2019.04.002 (2019).
Ge, J. et al. Comparison of nanoparticle-selenium, selenium-enriched yeast and sodium selenite on the alleviation of cadmium-induced inflammation via NF-kB/IκB pathway in heart. Sci. Total Environ. 773, 145442. https://doi.org/10.1016/j.scitotenv.2021.145442 (2021).
Zhe-Wei, S., Li-Sha, G. & Yue-Chun, L. The role of necroptosis in cardiovascular disease. Front. Pharmacol. 9, 721. https://doi.org/10.3389/fphar.2018.00721 (2018).
McGrath, J. C., Drummond, G. B., McLachlan, E. M., Kilkenny, C. & Wainwright, C. L. Guidelines for reporting experiments involving animals: The ARRIVE guidelines. Br. J. Pharmacol. 160, 1573–1576. https://doi.org/10.1111/j.1476-5381.2010.00873.x (2010).
National Research Council Committee for the Update of the Guide for the, C. & Use of Laboratory, A. in Guide for the Care and Use of Laboratory Animals (National Academies Press (US) Copyright © 2011, National Academy of Sciences, 2011).
Fahmy, S. R. & Gaafar, K. Establishing the first institutional animal care and use committee in Egypt. Philos. Ethics Humanities Med. PEHM 11, 2. https://doi.org/10.1186/s13010-016-0035-3 (2016).
Funding
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).
Author information
Authors and Affiliations
Contributions
E.H.: conceptualization, data curation, writing-original draft preparation, formal analysis. A.B.: methodology, visualization, reviewing and editing, investigation, resources. E.E.-S.: methodology, validation, investigation, resources, reviewing and editing. L.A.: methodology, validation, investigation, resources, reviewing, and editing. F.A.: conceptualization, methodology, data curation, methodology, reviewing, and editing.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hassanein, E.H.M., Bakr, A.G., El-Shoura, E.A.M. et al. Acetovanillone augmented the cardioprotective effect of carvedilol against cadmium-induced heart injury via suppression of oxidative stress and inflammation signaling pathways. Sci Rep 13, 5278 (2023). https://doi.org/10.1038/s41598-023-31231-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-31231-5
- Springer Nature Limited
This article is cited by
-
Carvedilol induces pyroptosis through NLRP3-caspase1-ASC inflammasome by nuclear migration of NF-κB in prostate cancer models
Molecular Biology Reports (2024)
-
Targeting necroptosis in fibrosis
Molecular Biology Reports (2023)